BAYRY - Biden administration says Supreme Court should reject Bayer Roundup appeal

The Department of Justice is siding with the plaintiff as Bayer (OTCPK:BAYRY) goes to the U.S. Supreme Court to try to stop potentially billions of dollars in claims that its Roundup weedkiller causes cancer, Bloomberg reported Tuesday. Bayer (OTCPK:BAYRY) is challenging a $25M award to a California man who says his exposure to Roundup caused non-Hodgkin's lymphoma, but the company claims federal approval of Roundup's label meant the lawsuit and others like it should not move forward. At the Supreme Court, Bayer (OTCPK:BAYRY) argues that the Federal Insecticide, Fungicide and Rodenticide Act - which says states may not impose packaging or labeling requirements that are "in addition to or different from" those under the federal law - shields the company from liability. The plaintiff's lawyers are urging the Supreme Court not to hear the case, saying the jury award is consistent with a 2005 Supreme Court ruling that allowed state-law

For further details see:

Biden administration says Supreme Court should reject Bayer Roundup appeal